WallStreetZenWallStreetZen

NASDAQ: COGT
Cogent Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

COGT past revenue growth

How has COGT's revenue growth performed historically?
Company
N/A
Industry
148.64%
Market
17.33%
COGT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
COGT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

COGT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$192.4M
Current Profit Margin
0%

COGT Return on Equity

Current Company
-67.9%
Current Industry
-63.5%
Current Market
188%
COGT's Return on Equity (-67.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when COGT announces earnings.

COGT Return on Assets

Current Company
-58.1%
Current Industry
2.9%
COGT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

COGT Return on Capital Employed

Current Company
-69.9%
Current Industry
19.5%
COGT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

COGT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
COGT$0.00-$188.82M-$192.41M-100.00%N/A
ELVN$0.00-$70.98M-$71.58MN/AN/A
PRTC$15.62M-$97.18M-$50.35M+43.86%N/A
CGEM$0.00-$166.97M-$153.16M-100.00%N/A
LBPH$0.00-$54.42M-$54.42MN/AN/A
View Top Biotech Stocks

COGT earnings dates

Next earnings date
May 7, 2024

Cogent Biosciences Earnings & Revenue FAQ

What were COGT's earnings last quarter?

On Invalid Date, Cogent Biosciences (NASDAQ: COGT) reported Q4 2023 earnings per share (EPS) of -$0.63, up 14.55% year over year. Total Cogent Biosciences earnings for the quarter were -$54.37 million. In the same quarter last year, Cogent Biosciences's earnings per share (EPS) was -$0.55.

If you're new to stock investing, here's how to buy Cogent Biosciences stock.

What was COGT's earnings growth in the past year?

As of Q2 2024, Cogent Biosciences's earnings has grown year over year. Cogent Biosciences's earnings in the past year totalled -$192.41 million.

What is COGT's earnings date?

Cogent Biosciences's earnings date is Invalid Date. Add COGT to your watchlist to be reminded of COGT's next earnings announcement.

What was COGT's revenue last quarter?

On Invalid Date, Cogent Biosciences (NASDAQ: COGT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cogent Biosciences's revenue was $0.00.

What was COGT's revenue growth in the past year?

As of Q2 2024, Cogent Biosciences's revenue has grown null year over year. Cogent Biosciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.